Trust in the European country's functioning democracy and institutions plummets to below 60 percent, research by the Friedrich Ebert Foundation shows.
Some 4 percent played down crimes committed by Hitler and praised Nazi ideology or policies. / Photo: Reuters ArchiveThe research by Friedrich Ebert Foundation published on Thursday has found that the number of people with far-right views has significantly increased in the past two years and has exceeded 8 percent.
In the foundation’s 2020/2021 survey, less than 2 percent of the respondents had clearly expressed support for right-wing extremist views. Researchers said the consequences of the Russia-Ukraine conflict, skyrocketing energy prices, and high inflation are creating challenges for the democratic parties in the centre, and strengthening the far-right.
“Insecurities and conflicts over who gets what and how much are providing a gateway for right-wing extremist ideologies and anti-democratic attitudes,” the researchers said in a summary of their report.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Germany seeks answers from Poland in a visa fraud scandal involving migrants from Asia and AfricaGerman government officials have held talks with their Polish counterparts asking them to clarify how many visas were issued in an illegal program in which some Polish consulates issued visas in Africa and Asia in exchange for bribes.
Read more »
European stocks continue losing streak, drop for second sessionEuropean stocks were flat Tuesday, as the Stoxx Europe 600 index finished down 0.04% to 456.52. The German DAX fell 0.40% to 15,664.48, the French CAC 40...
Read more »
People can’t believe the difference between American and European FantaWhy does the color of the orange soda differ so drastically between the U.S. and Europe?
Read more »
European Commission authorizes GSK's HIV prevention drugThe European Commission has granted authorization to GSK's HIV-focused division, ViiV Healthcare, for its cabotegravir in both long-acting injectable and tablet forms.
Read more »
European Commission Approves Ritlecitinib for Severe AAThis makes ritlecitinib the first medicine authorized by the EC to treat individuals with severe alopecia areata as young as 12 years of age.
Read more »
European stocks set for mixed open as global markets await the Fed's rate decisionEuropean markets are heading for a mixed open Wednesday as global investors await the latest monetary policy decision from the U.S. Federal Reserve.
Read more »